Skip to main content
Equibles

LSBWF · LakeShore Biopharma Co., Ltd.

Track LSBWF — free

Use LSBWF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LSBWF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 At close · Jul 6
Rebalance outlook locked
Market Cap
$2.76M
Shares
41.21M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.01 Open$0.01 Day$0.01–0.01 Available close range$0.01–0.01 Avg vol since split · 1d98K Short int1K · 0.0% float Short vol100% DataJul 2026–Jul 2026

Raw chart and full-history price indicators begin at the captured split on Oct 4, 2024; bars on opposite sides are not compared.

The closing range uses available history since Jul 6, 2026; less than a full year is stored.

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Limited Momentum Limited Sentiment Bearish Fundamentals Fair Quant / Vol Limited
Market backdrop VIX 15.4 · calm Equity put/call 0.52
Technical
price trend
Limited
Not enough data for a confident read.
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
-88% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Fundamentals
Fair
Revenue growth +6%
Y/Y
Gross margin 82%
expanding
EPS growth +87%
Y/Y
Free cash flow $-18.6M
Balance sheet $42.7M
net debt
Quant / Vol
risk profile
Limited
Not enough data for a confident read.

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
0 · 1 · 0
50 / 200-day cross
No cross Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
-88% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its available closing range
Price range unavailable — no recent comparable closes.

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LSBWF
LakeShore Biopharma Co., Ltd.
this stock
$2.76M — +6.0% — 0.0%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.06B +13.9% +46.2% 29.9 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $79.83B +2.3% +20.8% 19.2 2.5%
ARGX
Argenx SE
 $60.93B +18.4% — — 2.0%
CSLLY
Csl Ltd
 $59.64B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
1
% held
0.1%
Net QoQ
-298.7K sh
Top holder
BARCLAYS PLC
Held Float
View
Short & Settlement
Short Interest
Shares short
1.0K
Days to cover
1000.0d
Change
0 sh
View
Short Volume
Short vol %
100%
As of
Jun 9, 2026
Short Total
View
Fails to Deliver
FTD shares
549
Value
$27
As of
Mar 12, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Jul 6, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
CNY 615.0M
Net income (FY)
CNY -100.0M
EPS diluted
CNY -5.22
View
Filings
SEC Filings
Latest
6-K
Filed
Jun 24, 2026
This year
8
View

Performance

Raw-price comparisons begin at the captured split on Oct 4, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
LSBWF — — — — —
SPY +3.1% -0.8% +8.2% +0.6% +10.2%
vs SPY — — — — —
Key facts CIK 1946399 CUSIP G9845F208 Visit website